BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Cyclin dependent kinase 5 (CDK5)

August 4, 2016 7:00 AM UTC

Patient sample and mouse studies suggest inhibiting CDK5 could help treat medulloblastoma and other cancers. In six medulloblastoma patients, high tumor levels of CDK5 were associated with low T cell ...